DMD and Duchenne muscular dystrophy: Despite initial encouraging results with intramuscular injections of drisapersen in four DMD patients [110,111,112], phase II and phase III clinical trials have failed to demonstrate a significant clinical benefit or a clear increase in dystrophin expression [113,114].